These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23104711)

  • 1. Effects of fluid load on human urine characteristics related to workplace drug testing.
    Chaturvedi AK; Sershon JL; Craft KJ; Cardona PS; Soper JW; Canfield DV; Dubowski KM; Whinnery JE; Leyva MJ; Aston CE; Blevins SM; Wright JE; Fraser AD; Kuntz DJ
    J Anal Toxicol; 2013; 37(1):5-10. PubMed ID: 23104711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The defined HHS/DOT substituted urine criteria validated through a controlled hydration study.
    Edgell K; Caplan YH; Glass LR; Cook JD
    J Anal Toxicol; 2002 Oct; 26(7):419-23. PubMed ID: 12422995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of the Department of Transportation criteria for a substituted urine specimen.
    Barbanel CS; Winkelman JW; Fischer GA; King AJ
    J Occup Environ Med; 2002 May; 44(5):407-16. PubMed ID: 12024686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.
    Cone EJ; Lange R; Darwin WD
    J Anal Toxicol; 1998 Oct; 22(6):460-73. PubMed ID: 9788521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catching Fakes: New Markers of Urine Sample Validity and Invalidity.
    Goggin MM; Tann CM; Miller A; Nguyen A; Janis GC
    J Anal Toxicol; 2017 Mar; 41(2):121-126. PubMed ID: 27881620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatinine excretion in consecutive urine samples after controlled ingestion of water.
    Franz S; Skopp G; Boettcher M; Musshoff F
    Drug Test Anal; 2019 Mar; 11(3):435-440. PubMed ID: 30276981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Urine Protein/Creatinine Ratio Is Influenced by Urine Concentration.
    Yang CY; Chen FA; Chen CF; Liu WS; Shih CJ; Ou SM; Yang WC; Lin CC; Yang AH
    PLoS One; 2015; 10(9):e0137460. PubMed ID: 26353117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine Creatinine Concentrations in Drug Monitoring Participants and Hospitalized Patients.
    Love SA; Seegmiller JC; Kloss J; Apple FS
    J Anal Toxicol; 2016 Oct; 40(8):659-662. PubMed ID: 27590035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of human urine for specimen validity determination in workplace drug testing: a review.
    Cook JD; Caplan YH; LoDico CP; Bush DM
    J Anal Toxicol; 2000 Oct; 24(7):579-88. PubMed ID: 11043663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine specimen validity test for drug abuse testing in workplace and court settings.
    Lin SY; Lee HH; Lee JF; Chen BH
    J Food Drug Anal; 2018 Jan; 26(1):380-384. PubMed ID: 29389577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of urinary pteridines by urine specific gravity for early cancer detection.
    Burton C; Shi H; Ma Y
    Clin Chim Acta; 2014 Aug; 435():42-7. PubMed ID: 24792383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of urinary drug concentrations with specific gravity and creatinine.
    Cone EJ; Caplan YH; Moser F; Robert T; Shelby MK; Black DL
    J Anal Toxicol; 2009; 33(1):1-7. PubMed ID: 19161663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine drug screens.
    Cockrell K
    Indiana Med; 1991 Jun; 84(6):416-7. PubMed ID: 1918913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.